Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi AGM Information 2010

Apr 30, 2010

1643_iss_2010-04-30_708111e1-c809-4b0b-a61d-5d56f6a0ad05.pdf

AGM Information

Open in viewer

Opens in your device viewer

Paris, France, April 30, 2010

Board of Directors

Combined General Meeting of May 17, 2010

Following the withdrawal by Catherine Bréchignac of her candidature for the position of Director on the sanofi-aventis Board of Directors for personal reasons, the sanofi-aventis Board of Directors meeting held on April 28, 2010 resolved not to propose a new director to the general shareholders meeting. As a result, the sixth resolution is moot, and is deleted with no effect on the numbering of the remaining resolutions. The agenda has been modified accordingly.

The convening notice is published in the April 30, 2010 issue of the Bulletin des Annonces Légales Obligatoires, and is available on the Company website at: en.sanofi-aventis.com (under Investors/General Meeting 2010).

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, please visit: www.sanofi-aventis.com.

Contact :

Investor Relations Tel: + 33 (0)1 53 77 45 45 174, avenue de France - 75013 Paris

1 / 1